Bill & Melinda Gates Foundation

220 articles about Bill & Melinda Gates Foundation

• Statement from Bill & Melinda Gates Foundation CEO Mark Suzman on Momentum in Global COVID-19 Response

  9/30/2020

  The death toll from COVID-19 passed one million this week. It is a sobering moment. But there is cause for optimism as recent days have seen a significant surge in momentum around global cooperation, which is our greatest strength when it comes to consigning this pandemic to the history books.

• Acceligen Launches Program for Precision Crossbreeding of African Dairy Production Systems

  9/24/2020

   Acceligen, a Recombinetics Inc. company, today announced that it received a grant from the Bill & Melinda Gates Foundation to develop bovine genetics optimized with traits desirable to smallholder dairy farmers. The breeding program will contribute to more sustainable production by using traits that will increase farmer income

• Gates Foundation Honors Director of Africa CDC With 2020 Global Goalkeeper Award

  9/22/2020

  Foundation also announces three Global Goals award winners and launches two innovative partnerships to address COVID-19 impacts in Kenya

• Gates Foundation's Annual Goalkeepers Report Shows COVID-19 Has Stalled 20 Years of Progress, Calls for Global Response to End the Pandemic

  9/15/2020

  Report shows how economic damage has reinforced inequities and derailed achievement of the UN Sustainable Development Goals; spotlights countries innovating to meet challenges

• Relation Therapeutics Teams up With Mila in Coalition to Identify COVID-19 Therapeutic Candidates

  9/1/2020

  Relation Therapeutics, a drug development company driven by data science and machine learning, announces Project RE, which will apply Relation Therapeutics’ and its partners’ technology to the identification of repurposed drug combinations as potential therapeutic candidates for COVID-19.

• Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa

  8/17/2020

  Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the beginning of a Phase 2b clinical trial in South Africa to evaluate the efficacy of NVX-CoV2373, Novavax’ COVID-19 vaccine candidate.

• Dynavax Announces Grant to Scale up CpG 1018 Adjuvant Capacity to Support the Global COVID-19 Response

  8/13/2020

  Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced a grant from the Bill & Melinda Gates Foundation of $3.4 million to scale up production batch size to allow for increased capacity of Dynavax’s CpG 1018 advanced adjuvant to support the global COVID-19 response. These efforts will support capacity of up to 750 million adjuvant d

• HJFMRI Receives Grant to Research COVID-19 Impact on Pregnant Women and Newborns

  8/11/2020

  HJF Medical Research International  (HJFMRI), a wholly owned subsidiary of The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) , was awarded $1.3M by the Bill & Melinda Gates Foundation to support antenatal, intrapartum and postnatal care in the Kenya Child Health and Mortality Surveillanc

• 

  Biopharma Update on the Novel Coronavirus: July 10

  7/10/2020

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 10, 2020.

• Kleo Pharmaceuticals Announces $5 Million Grant to Advance Development of COVID-19 Hyperimmune Globulin Mimic (HGM) as a Therapeutic for Infected Patients

  7/8/2020

  The Grant from the Bill & Melinda Gates Foundation Accelerates Company’s Efforts to Enter Clinical Trials by Early 2021

• Daré Bioscience Announces Receipt of $1.5 Million Under the Current Grant Supplement Award for Continued Development of User-Controlled Long Acting Reversible Contraceptive

  6/15/2020

  Contraceptive Program Supported by up to $20.5 Million in Grant Funding from the Bill & Melinda Gates Foundation

• Bill & Melinda Gates Foundation pledges $1.6 billion to Gavi, the Vaccine Alliance, to protect the next generation with lifesaving vaccines

  6/4/2020

  Global leaders unite to safeguard 300 million more children from disease and mitigate consequences of COVID-19

• 'Hygiene Hub' links science to action to help save lives during COVID-19

  5/29/2020

  New online portal provides 'real-time' support and latest evidence for hygiene interventions actors, supported by funding from DFID and Bill & Melinda Gates Foundation

• New Research Highlights Disparity of Economic, Educational, and Social Impact of COVID-19 Based on Race, Gender, and Income

  5/18/2020

  Data science firm Civis Analytics released new findings from its COVID-19 Impact Research, funded by the Bill & Melinda Gates Foundation.

• Montreal Heart Institute Colcorona Study receives grant from the COVID-19 Therapeutics Accelerator via the Bill & Melinda Gates Foundation to investigate cheap, readily available drug

  5/12/2020

  Clinical study evaluating colchicine as a potential treatment to reduce inflammatory conditions seen in patients with COVID-19

• The Wistar Institute and Batavia Biosciences Launch Collaboration to Manufacture and Distribute Wistar’s Rubella Vaccine Globally

  4/29/2020

  The Bill & Melinda Gates Foundation supports international collaboration to expand global access to life-saving vaccines

• 

  Biopharma Update on the Novel Coronavirus: April 24

  4/24/2020

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 24, 2020.

• Certara Launches COVID-19 Pharmacology Online Resource Center

  4/7/2020

  Funded by the Bill & Melinda Gates Foundation, the online Center helps accelerate therapeutics for COVID-19 by integrating clinical pharmacology, innovation and collaboration

• Chan Zuckerberg Initiative Commits $25 Million to Speed Development of COVID-19 Treatments

  3/27/2020

  CZI Joins Bill & Melinda Gates Foundation, Wellcome, Mastercard in Standing up "COVID-19 Therapeutics Accelerator"

• Algernon Contacts Gates Foundation Regarding Funding for New Coronavirus Treatments

  3/13/2020

  Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company is pleased to announce that it has contacted the Bill & Melinda Gates Foundation in order to seek funding under the recently announced COVID-19 Therapeutic Accelerator program.